中文名称:
[2-甲氧基-4-[(4-氧代-2-硫代-5-噻唑烷亚基)甲基]苯氧基]乙酸乙酯
中文同义词:
[2-甲氧基-4-[(4-氧代-2-硫代-5-噻唑烷亚基)甲基]苯氧基]乙酸乙酯;NOTCH抑制剂(IMR-1)
英文同义词:
IMR-1, >98%;IMR-1;[2-Methoxy-4-[(4-oxo-2-thioxo-5-thiazolidinylidene)methyl]phenoxy]acetic acid ethyl ester;Acetic acid, 2-[2-methoxy-4-[(4-oxo-2-thioxo-5-thiazolidinylidene)methyl]phenoxy]-, ethyl ester;IMR-1 >=98% (HPLC);2-Methoxy-4-(4-oxo-2-thioxo-thiazolidin-5-ylidenemethyl)-phenoxy]-acetic acid ethyl ester
储存条件
Keep in dark place,Sealed in dry,2-8°C
概述
在许多癌症中,已经证明异常Notch活性在肿瘤表型和癌症干细胞的起始和维持中起作用,这可能暗示其额外参与转移和对治疗的抗性。因此,Notch是一种极具吸引力的癌症治疗靶点,但该途径中的各种潜在靶点尚未得到充分研究。迄今为止,还没有小分子抑制剂直接靶向细胞内Notch途径或转录激活复合物的组装。
生物活性
IMR-1是靶向转录激活过程的新型Notch抑制剂,其IC50为26 μM。
靶点
Target Value
Notch
(Cell-free assay) 26 μM
Notch
(Cell-free assay)
26 μM
体内研究
IMR-1 (i.p.; 15mg/kg; for 28 days) inhibits Notch-dependent tumor growth in patient-derived xenograft models.
Animal Model: Nude mouses with adenocarcinoma xenograft
Dosage: 15mg/kg
Administration: I.p.; for 28 days
Result: Blocks tumor establishment.
Animal Model:
Nude mouses with adenocarcinoma xenograft
Administration:
I.p.; for 28 days
Result:
Blocks tumor establishment.